# Zymeworks (stock symbol: ZYME) Logo in transparent PNG and SVG formats

## Zymeworks Logo large

### Zymeworks Logo large Download PNG (34.25 KB)

![Zymeworks Logo large Download PNG (34.25 KB)](/img/orig/ZYME_BIG-bed45938.png)

### Zymeworks Logo large Download SVG (4.16 KB)

![Zymeworks Logo large Download SVG (4.16 KB)](/img/orig/ZYME_BIG-186baaa2.svg)

## Zymeworks Logo icon format

### Zymeworks Logo icon format Download PNG (39.51 KB)

![Zymeworks Logo icon format Download PNG (39.51 KB)](/img/orig/ZYME-b0423c8f.png)

### Zymeworks Logo icon format Download SVG (2.42 KB)

![Zymeworks Logo icon format Download SVG (2.42 KB)](/img/orig/ZYME-a6a0a57e.svg)

## Zymeworks Logo large for dark backgrounds

### Zymeworks Logo large for dark backgrounds Download PNG (22.69 KB)

![Zymeworks Logo large for dark backgrounds Download PNG (22.69 KB)](/img/orig/ZYME_BIG.D-2d454e08.png)

### Zymeworks Logo large for dark backgrounds Download SVG (4.69 KB)

![Zymeworks Logo large for dark backgrounds Download SVG (4.69 KB)](/img/orig/ZYME_BIG.D-a60857aa.svg)

## Zymeworks Logo icon format for dark backgrounds

### Zymeworks Logo icon format for dark backgrounds Download PNG (22.43 KB)

![Zymeworks Logo icon format for dark backgrounds Download PNG (22.43 KB)](/img/orig/ZYME.D-93a9e89a.png)

### Zymeworks Logo icon format for dark backgrounds Download SVG (2.7 KB)

![Zymeworks Logo icon format for dark backgrounds Download SVG (2.7 KB)](/img/orig/ZYME.D-55052d59.svg)

## About Zymeworks

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. It is also advancing a pipeline of preclinical product candidates and discovery-stage programs in oncology, including immuno-oncology agents and other therapeutic areas. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; BeiGene, Ltd.; and Exelixis, Inc. It also has licensing and research collaboration with LEO Pharma A/S to research, develop, and commercialize bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was incorporated in 2003 and is headquartered in Vancouver, Canada.

1. Website domain: zymeworks.com
2. Employees: 286
3. Marketcap: $0.53 Billion USD


## Categories
- [x] ðŸ‡¨ðŸ‡¦ Canada
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
